PS1003 HARMONY ALLIANCE: EUROPEAN PUBLIC‐PRIVATE DATA COLLECTION LEADS THE WAY ‐ FIRST RESULTS OF THE “PROOF‐OF‐PRINCIPLE” STUDY IN ACUTE MYELOID LEUKEMIA
Lars Bullinger(Stanford University), G.J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Michel van Speybroeck(Janssen (Belgium)), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Jorge Sierra(Universitat Autònoma de Barcelona), Klaus H. Metzeler(University Hospital Leipzig), Jurjen Versluis(Erasmus MC), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), R. Goodbody(AbbVie (Ireland)), Miodrag Vukčević(Novartis (Switzerland)), Filippo Lococo(Università Cattolica del Sacro Cuore), Frédérik Damm(Humboldt-Universität zu Berlin), Renate Schulze‐Rath(Sanofi (France)), Guillermo Sanz(Instituto de Salud Carlos III), Hervé Dombret(European Union), Maria Teresa Voso(University of Rome Tor Vergata), Rubén Villoria Medina(GMV Innovating Solutions (Spain)), Jens-Peter Mayer(University Hospital Brno), Peter J.M. Valk(Erasmus MC Cancer Institute), Juan Manuel Herrera Hernández(Instituto de Investigación Biomédica de Salamanca), Ken Mills(Johns Hopkins University), Rosa Ayala(Hospital Universitario 12 De Octubre), Sergio Amadori(Polyclinic Medical Center), P. M. Bacon(Bristol-Myers Squibb (Switzerland)), Hartmut Döhner(University Hospital Ulm), John-Edward Butler-Ransohoff(Bayer (Germany)), Pau Montesinos(Instituto de Salud Carlos III), W. Hiddemann(Ludwig-Maximilians-Universität München), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k